Press Releases

Mithra Initiates Phase III Clinical Program for Donesta®
9 October 2019
EN FR

Mithra Provides Supplementary Details on Estelle® US Deal with Mayne
3 October 2019
EN FR

Mithra Sucessfully Renegotiates Earnout Payments
1 October 2019
EN FR

Mithra Signs Landmark Contract for Estelle® in the United States with Mayne Pharma
1 October 2019
EN FR

Mithra Announces 2019 Half Year Results
19 September 2019
EN FR

Interim Financial Report as at 30 June 2019
19 September 2019
EN FR

Mithra Signs LSA for Commercialization of Estelle® and Myring™ in Israel
20 August 2019
EN FR

Mithra obtains crucial additional Estelle® patent in Japan
8 August 2019
EN FR

Mithra CDMO Strengthens its Management Team and Accelerates Key R&D Programs
16 July 2019
EN FR

Mithra Signs LSA for Commercialization of Myring™ in Germany, the biggest market in Europe
28 May 2019
EN FR

Tibelia®, First Tibolone-Based Hormone Therapy Approved in Canada
15 May 2019
EN FR

Information on the Total Number of Voting Rights (Denominator)
29 April 2019
EN FR